|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.415 AUD | +2.47% |
|
-3.49% | -12.63% |
MGC Pharmaceuticals Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was AUD 3.39 million compared to AUD 4.73 million a year ago. Net loss was AUD 20.82 million compared to AUD 20.35 million a year ago.
Basic loss per share from continuing operations was AUD 7.1 compared to AUD 7.9 a year ago. Diluted loss per share from continuing operations was AUD 7.1 compared to AUD 7.9 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.63% | 12.25M | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
ARGENT BIOPHARMA LIMITED 
